Induction of MLR-Bf and protection of fetal loss: A current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion

International Immunopharmacology

Volumn 4, Issue 2, 2004, Pages 289-298

  Pandey, Manoj Kumar ^a   Agrawal, Suraksha ^b  

^a MAYO CLINIC   (United States)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Lymphocyte immunotherapy; Mixed lymphocyte reaction blocking antibodies; Recurrent spontaneous abortion

Indexed keywords

ANTIBODY; MIXED LYMPHOCYTE REACTION BLOCKING ANTIBODY; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ADULT; ARTICLE; CELL SUSPENSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FETUS WASTAGE; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MIXED LYMPHOCYTE REACTION; PATERNAL LYMPHOCYTE IMMUNOTHERAPY; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT ABORTION; SPONTANEOUS ABORTION; THIRD TRIMESTER PREGNANCY;

ABORTION, HABITUAL; ADULT; ANTIBODIES, BLOCKING; DOUBLE-BLIND METHOD; FATHERS; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, PASSIVE; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTE TRANSFUSION; MALE; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES;

EID: 1542302654     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.01.001     Document Type: Article

References (62)

1. Warburton D., Kline J., Stein Z., Hutzler M., Chin A., Hassold T. Does the karyotype of a spontaneous abortion predict the karyotype of a subsequent abortion? Evidence from 273 women with two karyotyped spontaneous abortion. Am. J. Hum. Genet. 41:1983;465-483.
2. Smith J.B., Cowchock F.S. Immunological studies in recurrent spontaneous abortion: effects of immunization of women with paternal mononuclear cells on lymphocytotoxic and mixed lymphocyte reaction blocking antibodies and correlation with sharing of HLA and pregnancy outcome. J. Reprod. Immunol. 14:1988;99-113.
3. Edmonds D.K., Lindsay K.S., Miller J.F., Williamson E., Wood P.J. Early embryonic mortality in women. Fertil. Steril. 38:1982;447-453.
4. Coulam C.B. Report from the ethics committee for immunotherapy. Am. J. Reprod. Immunol. 30:1993;45-47.
5. Strobino B., Warburton D. Reed G.B., Wairnex A.E., Cockburn F. 2nd ed. Recurrent Abortion: Genetic and Other non Immune Factors Diseases of the Foetus and Newborn, Pathology, Imaging Genetics and Management. 1:1995;167 Chapman & Hall.
6. Stern J.J., Dorfmann A.D., Gutierrez-Najar A.J., Cerrillo M., Coulam C.B. Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil. Steril. 65(2):1996;233-250.
7. Ohno M., Maeda T., Matsunobu A. A cytogenetic study of spontaneous abortions with direct analysis of chorionic villi. Obstet. Gynecol. 177(3):1999;394-398.
8. Hill J.A., Polgar K., Harlow B.L., Anderson D.J. Evidence of embryo- and trophoblast-toxic cellular immune responses in women with recurrent spontaneous abortion. Am. J. Obstet. Gynecol. 166(4):1992;1044-1052.
9. Stephensen M.D. Frequency of factors associated with habitual abortion in 197 couples. Fertil. Steril. 66:1996;24-29.
10. Weltz J.I. Low molecular weight heparins. N. Engl. J. Med. 337:1997;688-697.
11. Clifford K., Rai R., Watson H., Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum. Reprod. 9(7):1994;1328-1332.
12. Torpin R. Placenta circumvallata and placenta marginata. Obstet. Gynecol. 21:1995;76-81.
13. Jaffe R., Jauniaux E., Hustin J. Maternal circulation in the first-trimester human placenta - myth or reality. Am. J. Obstet. Gynecol. 176(3):1997;695-705.
14. Lea R.G., Sharekh N., Tulppala M., Critchley H.O. The immunolocalization of bcl-2 at the maternal-fetal interface in healthy and failing pregnancies. Hum. Reprod. 12(1):1997;153-158.
15. Harlap S., Shiono P.H. Alcohol, smoking, and incidence of spontaneous abortions in the first and second trimester. Lancet. 2(8187):1980;173-176.
16. Polifka J.E., Friedman J.M. Environmental toxins and recurrent pregnancy loss. Infertil. Reprod. Med. Clin. North Am. 2:1991;175-213.
17. Agrawal S., Kishore R., Halder A., Sharma A., Sharma R.K., Das V.et al. Outcome of pregnancy in women with recurrent spontaneous abortion following immunotherapy with allogeneic lymphocytes. Hum. Reprod. 10:1995;2280-2284.
18. Kishore R., Agrawal S., Halder A., Das V., Shukla B.R. HLA sharing, anti-paternal cytotoxic antibodies and MLR blocking factors in women with recurrent spontaneous abortion. J. Obstet. Gynaecol. Res. 22(2):1996;177-183.
19. Petri M. Pathogenesis and treatment of the antiphospholipid antibody syndrome. Med. Clin.North Am. 81:1997;151-177.
20. Tamura M., Takakuwa K., Arakawa M., Yasuda M., Kazama Y., Tanaka K. Relationship between MLR blocking antibodies and the outcome of the third pregnancy in patients with two consecutive spontaneous abortions. J. Perinat. Med. 26:1998;49-53.
21. Ito K., Tanaka T., Tsutsumi N., Obata F., Kashiwagi N. Possible mechanisms of immunotherapy for maintaining pregnancy in recurrent spontaneous aborters: analysis of anti-idiotypic antibodies directed against autologous T-cell receptors. Hum. Reprod. 14(3):1999;650-655.
22. Orgad S., Loewenthal R., Gazit E., Sadetzki S., Novikov I., Carp H. The prognostic value of anti-paternal antibodies and leukocyte immunizations on the proportion of live births in couples with consecutive recurrent miscarriages. Hum. Reprod. 14(12):1999;2974-2979.
23. Raghupathy R., Makhseed M., Azizieh F., Omu A., Gupta M., Farhat R. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum. Reprod. 15(3):2000;713-718.
24. Agrawal S., Pandey M.K., Mandal S.K., Mishra L.C., Agarwal S.S. Humoral immune response to an allogenic foetus in normal fertile women and recurrent aborters. BMC Pregnancy Childbirth. 2:2002;1-6.
25. Malinowski A. Recurrent spontaneous abortion of alloimmunologic etiology diagnosis and immunotherapy. Ginekol. Pol. 72(11):2001;885-898.
26. Pandey M.K., Saxena V., Agrawal S. Characterization of mixed lymphocyte reaction blocking antibodies (MLR-Bf) in human pregnancy. BMC Pregnancy Childbirth. 3:2003;2.
27. Pandey M.K., Thakur S., Agrawal S. Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Arch. Gynecol. Obstet. 3:2004;1-28.
28. Warburton D., Fraser F.C. On the probability that a woman who has had a spontaneous abortion will abort in subsequent pregnancies. Br. J. Obstet. Gynaecol. 69:1961;784-787.
29. Regan L., Braude P.R., Trembath P.L. Influence of past reproductive performance on risk of spontaneous abortion. BMJ. 299(6698):1989;541-545.
30. Coulam C.B., Goodman C., Roussev R.G., Thomanson E.J., Beaman K.D. Systemic CD 56+ cells can predict pregnancy outcome. Am. J. Reprod. Immunol. 33:1995;40-46.
31. Ramhorst R., Agriello E., Zittermann S., Pando M., Larriba J., Irigoyen M.et al. Is the paternal mononuclear cells' immunization a successful treatment for recurrent spontaneous abortion. Am. J. Reprod. Immunol. 44:2000;129-135.
32. Mowbray J.F., Gibbings C., Liddell H., Reginald P.W., Underwood J.L., Beard R.W. Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet. 1(8435):1985;941-943.
33. Reznikoff-Etievant M.F., Durieux I., Huchet J., Slamon C., Neltor A. Human MHC antigens and paternal leukocyte injections in recurrent spontaneous abortions. Bear R.W., Sharp F. Early pregnancy loss: mechanisms and treatment. 1988;375-384 RCOG, London, UK.
34. Lubinski J., Vrdoljak V.J., Beaman K.D., Kwak J.Y., Beer A.E., Gilman-Sachs A. Characterization of antibodies induced by paternal lymphocyte immunization in couples with recurrent spontaneous abortion. J. Reprod. Immunol. 24(2):1993;81-96.
35. Sugi T., Makino T., Maruyama T., Nozawa S., Iizuka R. Influence of immunotherapy on antisperm antibody titer in unexplained recurrent aborters. Am. J. Reprod. Immunol. 29(2):1993;95-99.
36. Pandey M.K., Agrawal S. Prevalence of anti-idiotypic antibodies in pregnancy v/s recurrent spontaneous abortion (RSA) women. Obstet. Gynaecol. Today. 10:2002;574-578.
37. Beer A.E., Semprini A.E., Zhu X.Y., Quebbeman J.F. Pregnancy outcome in human couples with recurrent spontaneous abortions: HLA antigen profiles: HLA antigen sharing; female serum MLR blocking factors; and paternal leukocyte immunization. Exp. Clin. Immunogenet. 2(3):1985;137-153.
38. Takakuwa K., Goto S., Hasegawa I., Ueda H., Kanazawa K., Takeuchi S.et al. Result of immunotherapy on patients with unexplained recurrent abortion: a beneficial treatment for patients with negative blocking antibodies. Am. J. Reprod. Immunol. 23(2):1990;37-41.
39. Takakuwa K., Higashino M., Yasuda M., Ishii S., Ueda H., Asano K.et al. Is an additional vaccination necessary for a successful second pregnancy in unexplained recurrent aborters who were successfully immunized with their husband's lymphocytes before the first pregnancy. Am. J. Reprod. Immunol. 29:1993;39-44.
40. Daya S., Gunby J. The effectiveness of allogeneic leukocyte immunization in unexplained primary recurrent spontaneous abortion. Recurrent miscarriage immunotherapy trialists group. Am. J. Reprod. Immunol. 32(4):1994;294-302.
41. Malinowsky D., Alheim K., Chai Z., Fantuzzi G., Hasanvan H., Di Santo E.et al. Hyperresponsive febrile reactions to interleukin (IL) 1alpha and IL-1beta, and altered brain cytokine mRNA and serum cytokine levels, in IL-1beta-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 94:1997;2681-2686.
42. Li D., Li C., Zhu Y. Comparative study of the third party and paternal leukocyte immunization in recurrent spontaneous abortion of lowered maternal-fetal immuno-recognition. Zhonghua Fu Chan Ke Za Zhi. 33(10):1998;597-600.
43. Prigoshin N., Tambutti M.L., Redal M.A., Gorgorza S., Lancuba S.M., Nicholson R.et al. Microchimerism and blocking activity in women with recurrent spontaneous abortion (RSA) after alloimmunization with the partner's lymphocytes. J. Reprod. Immunol. 44(1-2):1999;41-54.
44. Agrawal S., Pandey M.K., Pandey A. Prevalence of MLR blocking antibodies before and after immunotherapy. J. Hematother. Stem Cell Res. 9:2000;257-262.
45. Adachi H., Takakuwa K., Mitsui T., Ishii K., Tamura M., Tanaka K. Results of immunotherapy for patients with unexplained secondary abortions. Clin. Immunol. 106:2003;175-180.
46. Gafter U., Sredni B., Segal J., Kalechman Y. Suppressed cell-mediated immunity and monocyte and natural killer cell activity following allogeneic immunization of women with spontaneous recurrent abortion. J. Clin. Immunol. 17(5):1997;408-419.
47. Kwak J.Y., Gilman-Sachs A., Moretti M., Beaman K.D., Beer A.E. Natural killer cell cytotoxicity and paternal lymphocyte immunization in women with recurrent spontaneous abortions. Am. J. Reprod. Immunol. 40(5):1998;352-358.
48. Hayakawa S., Karasaki-Suzuki M., Itoh T., Ishii M., Kanaeda T., Nagai N.et al. Effects of paternal lymphocyte immunization on peripheral Th1/Th2 balance and TCR V beta and V gamma repertoire usage of patients with recurrent spontaneous abortions. Am. J. Reprod. Immunol. 43(2):2000;107-115.
49. Clark D.A., Daya S. Trials and tribulation in the treatment of recurrent spontaneous abortion. Am. J. Reprod. Immunol. 25:1991;18-24.
50. Cauchi M.N., Lim D., Young D.E., Kloss M., Pepperell R.J. Treatment of recurrent aborters by immunization with paternal cells - controlled trial. Am. J. Reprod. Immunol. 25(1):1991;16-17.
51. Ho H.N., Gill T.J. III, Hsieh H.J., Jiang J.J., Lee T.Y., Hsieh C.Y. Immunotherapy for recurrent spontaneous abortions in a Chinese population. Am. J. Reprod. Immunol. 25(1):1991;10-15.
52. Gatenby P.A., Cameron K., Simes R.J., Adelstein S., Bennett M.J., Jansen R.P.et al. Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial. Am. J. Reprod. Immunol. 29(2):1993;88-94.
53. Illeni M.T., Marelli G., Parazzini F., Acaia B., Bocciolone L., Bontempelli M.et al. Immunotherapy and recurrent abortion: a randomized clinical trial. Hum. Reprod. 9(7):1994;1247-1249.
54. Carp H.J., Toder V., Torchinsky A., Portuguese S., Lipitz S., Gazit E.et al. Allogenic leukocyte immunization after five or more miscarriages: recurrent miscarriage immunotherapy trialists group. Hum. Reprod. 12(2):1997;250-255.
55. Ober C., Karrison T., Odem R.R., Barnes R.B., Branch D.W., Stephenson M.D.et al. Mononuclear-cell immunization in prevention of recurrent miscarriages: a randomized trial. Lancet. 354:1999;365-369.
56. Maejima M., Fujii T., Yamashita T., Hara N., Hamai Y., Miki A.et al. Immunotherapy before and during pregnancy improves pregnancy outcome in women who suffer from recurrent abortion and did not benefit from immunotherapy before pregnancy. Am. J. Reprod. Immunol. 39:1998;12-15.
57. Carp H.J., Toder V., Mashiach S. Immunotherapy of habitual abortion. Am. J. Reprod. Immunol. 28(3-4):1992;281-284.
58. Pearlman S.A., Meek R.S., Cowchock F.S., Smith J.B., Mc Farland J., Aster R.H. Neonatal alloimmune thrombocytopenia after maternal immunization with paternal mononuclear cells: successful treatment with intravenous gamma globulin. Am. J. Perinatol. 9(5-6):1992;448-451.
59. Recurrent Miscarriage Immunotherapy Trialists Group (RMITG) World wide collaborative observation study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am. J. Reprod. Immunol. 32:1994;55-72.
60. Chaouat G., Tranchot Diallo J., Volumenie J.L., Menu E., Gras G., Delage G.et al. Immune suppression and Th1/Th2 balance in pregnancy revisited: a (very) personal tribute to Tom Wegmann. Am. J. Reprod. Immunol. 37(6):1997;427-434.
61. Tanaka T., Umesaki N., Nishio J., Maeda K., Kawamura T., Araki N.et al. Neonatal thrombocytopenia induced by maternal anti-HLA antibodies: a potential side effect of allogenic leukocyte immunization for unexplained recurrent aborters. J. Reprod. Immunol. 46:2000;51-57.
62. Check J.H., Arwitz M., Gross J., Peymer M., Szekeres-Bartho J. Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF). Am. J. Reprod. Immunol. 37:1997;17-20.